Isolated limb infusion in a series of over 100 infusions: A single-center experience

Annals of Surgical Oncology

Volumn 20, Issue 4, 2013, Pages 1121-1127

  Wong, Joyce ^a   Chen, Y Ann ^a   Fisher, Kate J ^a   Zager, Jonathan S ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE;

ADULT; AGED; COHORT ANALYSIS; CONFERENCE PAPER; CREATINE KINASE BLOOD LEVEL; FEMALE; FOLLOW UP; HUMAN; ISOLATED LIMB INFUSION; LENGTH OF STAY; LIMB PERFUSION; MAJOR CLINICAL STUDY; MALE; MELANOMA; MERKEL CELL; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, MERKEL CELL; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; EXTREMITIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MELANOMA; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; SARCOMA; YOUNG ADULT;

EID: 84875212284     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-012-2782-8     Document Type: Conference Paper

References (26)

1. JF Thompson PC Kam RC Waugh CR Harman 1998 Isolated limb infusion with cytotoxic agents: a simple alternative to isolated limb perfusion Semin Surg Oncol 14 238 247 9548607 10.1002/(SICI)1098-2388(199804/05)14:3<238::AID- SSU8>3.0.CO;2-9 1:STN:280:DyaK1c3gvVertQ%3D%3D
2. MD Moncrieff HM Kroon PC Kam PD Stalley RA Scolyer JF Thompson 2008 Isolated limb infusion for advanced soft tissue sarcoma of the extremity Ann Surg Oncol 15 2749 2756 18648882 10.1245/s10434-008-0045-5
3. KK Turaga GM Beasley JM Kane, et al. 2011 Limb preservation with isolated limb infusion for locally advanced nonmelanoma cutaneous and soft-tissue malignant neoplasms Arch Surg 146 870 875 21768436 10.1001/archsurg.2011.139
4. HM Kroon M Moncrieff PC Kam JF Thompson 2008 Outcomes following isolated limb infusion for melanoma: a 14-year experience Ann Surg Oncol 15 3003 3013 18509706 10.1245/s10434-008-9954-6
5. A Sanki PC Kam JF Thompson 2007 Long-term results of hyperthermic, isolated limb perfusion for melanoma a reflection of tumor biology Ann Surg 245 591 596 17414608 10.1097/01.sla.0000251746.02764.fc
6. GM Beasley A Caudle RP Petersen, et al. 2009 A multi-institutional experience of isolated limb infusion: defining response and toxicity in the US J Am Coll Surg 208 706 717 19476821 10.1016/j.jamcollsurg.2008.12.019
7. GM Beasley C Parsons G Broadwater, et al. 2012 A multicenter prospective evaluation of the clinical utility of F-18 FDG-PET/CT in patients with AJCC stage IIIB or IIIC extremity melanoma Ann Surg 256 350 356 22691370 10.1097/SLA.0b013e318256d1f5
8. CY Chai JL Deneve GM Beasley, et al. 2012 A multi-institutional experience of repeat regional chemotherapy for recurrent melanoma of extremities Ann Surg Oncol 19 1637 1643 22143576 10.1245/s10434-011-2151-z
9. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, editors. AJCC cancer staging manual. 7th ed. New York: Springer; 2010. p 325-44.
10. TG Zogakis R Essner HJ Wang LJ Foshag DL Morton 2007 Natural history of melanoma in 773 patients with tumor-negative sentinel lymph nodes Ann Surg Oncol 14 1604 1611 17333418 10.1245/s10434-006-9267-6
11. TM Pawlik MI Ross MM Johnson, et al. 2005 Predictors and natural history of in-transit melanoma after sentinel lymphadenectomy Ann Surg Oncol 12 587 596 16021533 10.1245/ASO.2005.05.025
12. A Testori C Verhoef HM Kroon, et al. 2011 Treatment of melanoma metastases in a limb by isolated limb perfusion and isolated limb infusion J Surg Oncol 104 397 404 21858835 10.1002/jso.22029
13. A Testori MB Faries JF Thompson, et al. 2011 Local and intralesional therapy of in-transit melanoma metastases J Surg Oncol 104 391 396 21858834 10.1002/jso.22029
14. S Bonvalot A Laplanche F Lejeune, et al. 2005 Limb salvage with isolated perfusion for soft tissue sarcoma: could less TNF-alpha be better? Ann Oncol 16 1061 1068 15930042 10.1093/annonc/mdi229 1:STN:280:DC%2BD2MzhsFSjuw%3D%3D
15. JP Deroose AM Eggermont AN Van Geel, et al. 2011 Long-term results of tumor necrosis factor α- and melphalan-based isolated limb perfusion in locally advanced extremity soft tissue sarcomas J Clin Oncol 29 4036 4044 21931039 10.1200/JCO.2011.35.6618 1:CAS:528:DC%2BC3MXhsFams7bE
16. CT Klopp TC Alford J Bateman GN Berry T Winship 1950 Fractionated intra arterial cancer chemotherapy Ann Surg 132 811 832 14771793 10.1097/00000658- 195010000-00018 1:STN:280:DyaG3M%2FgtFensQ%3D%3D
17. OJ Creech ET Krementz RF Ryan JN Winblad 1958 Chemotherapy of cancer: regional perfusion using an extracorporeal circuit Ann Surg 148 616 632 13583933 10.1097/00000658-195810000-00009
18. JS Stehlin 1969 Hyperthermic perfusion with chemotherapy for cancers of the extremity Surg Gyncol Obstet 129 305 308
19. R Cumberlin E De Moss M Lassus M Friedman 1985 Isolated perfusion for malignant melanoma of the extremity: a review J Clin Oncol 3 1022 1031 2410572 1:STN:280:DyaL2M3mtlOhsw%3D%3D
20. GM Beasley RP Petersen J Yoo, et al. 2008 Isolated limb infusion for in-transit malignant melanoma of the extremity: a well-tolerated but less effective alternative to hyperthermic isolated limb perfusion Ann Surg Oncol 15 2195 2205 18528730 10.1245/s10434-008-9988-9
21. MA Hegazy SZ Kotb H Sakr, et al. 2007 Preoperative isolated limb infusion of doxorubicin and external irradiation for limb-threatening soft tissue sarcomas Ann Surg Oncol 14 568 576 17094027 10.1245/s10434-006-9138-1
22. HM Kroon DY Lin PC Kam JF Thompson 2009 Efficacy of repeat isolated limb infusion with melphalan and actinomycin D for recurrent melanoma Cancer 115 1932 1940 19288571 10.1002/cncr.24220 1:CAS:528:DC%2BD1MXlt1ygu7Y%3D
23. AK Raymond GM Beasley G Broadwater, et al. 2011 Current trends in regional therapy for melanoma: lessons learned from 225 regional chemotherapy treatments between 1995 and 2010 at a single institution J Am Coll Surg 213 306 318 21493111 10.1016/j.jamcollsurg.2011.03.013
24. AM Huismans HM Kroon PC Kam JF Thompson 2011 Does increased experience with isolated limb infusion for advanced limb melanoma influence outcome? A comparison of two treatment periods at a single institution Ann Surg Oncol 18 1877 1883 21499810 10.1245/s10434-011-1646-y
25. AA Santillan KA Delman GM Beasley, et al. 2009 Predictive factors of regional toxicity and serum creatine phosphokinase levels after isolated limb infusion for melanoma: a multi-institutional analysis Ann Surg Oncol 16 2570 2578 19543771 10.1245/s10434-009-0563-9
26. HR Alexander DL Fraker DL Bartlet, et al. 2010 Analysis of factors influencing outcome in patients with in-transit malignant melanoma undergoing isolated limb perfusion using modern treatment parameters J Clin Oncol 28 114 118 19901107 10.1200/JCO.2009.23.7511